Serving To Educate Primary Care Clinicians On Metabolic Issues
Home
Subscribe
Feedback
Contact Us
Evidence Based Medicine
Medical Education
Metabolic Diseases
About Us
PCMG CME
PCMG Non-CME
Resources
Needs Survey
Commentaries
Survey
Lipids Webinar Post Survey
I am a(n)…
[ Required ]
Select...
MD/DO
NP/RN
PA
Other
How many years have you been in practice?
[ Required ]
Select...
1-5
6-10
11-15
16-20
Over 20
What is your practice setting?
[ Required ]
Select...
Solo Practice
Group Practice
Hospital
Clinic
Academic
Other
Number of patients seen per month with hyperlipidemia
[ Required ]
Select...
1-10
11-20
21-30
31-40
41-50
Over 50
Please rate the following:
Degree to which your educational expectations were met
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Relevance to your practice
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Effective faculty presenter
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Overall Presentation
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Please rate the degree to which Learning Objectives were met.
Incorporate strategies that help patients achieve target LDL-C goals, based on current evidence and guideline recommendations.
[ Required ]
Select...
Completely
Mostly
Somewhat
Not at all
Implement personalized treatment plans for patients with residual CV risk, including newer agents such as PCSK9 inhibitors.
[ Required ]
Select...
Completely
Mostly
Somewhat
Not at all
Explain the role of Lp(a)in CV risk and the rationale for including Lp(a) in lipid screening practices.
[ Required ]
Select...
Completely
Mostly
Somewhat
Not at all
Agree or Disagree?
The presentation was fair and balanced, free of commercial bias.
[ Required ]
Select...
YES
NO
I feel more competent as a result of the presentation.
[ Required ]
Select...
YES
NO
The presentation was scientifically rigorous.
[ Required ]
Select...
YES
NO
The content contributed valuable information that will assist in improving patient outcomes
[ Required ]
Select...
Strongly Agree
Agree
Unsure
Disagree
Strongly Disagree
My participation in this activity will improve the efficacy of the healthcare team.
[ Required ]
Select...
Strongly Agree
Agree
Unsure
Disagree
Strongly Disagree
Will you change your practice behaviors as a result of the presentation?
[ Required ]
Select...
Absolutely
Probably
Unsure
Unlikely
No
What will you change?
[ Required ]
Evaluate CV risk using validated tools
Consider nonstatin therapies for residual CV risk
Test Lp(a) once per lifetime in adult patients
Intensify lipid-lowering therapy to meet LDL-C targets
Facilitate multidisciplinary care for lipid management
Educate my patients
Other
If Other
Because you are likely to make changes to your practice behaviors, you are eligible to qualify for T2P (Translation to Practice) Credit, an additional 2.0 Credits. Please provide your email address below and we will send you a link to a followup survey in six weeks. If you have made changes to your practice behaviors, you will receive those additional two credits.
[ Invalid e-mail address ]
What barriers to change do you foresee?
[ Required ]
Cost
Insurance Coverage
Formulary
Patient Adherence
Time with Patient
Other
None
If Other
What was your level of knowledge on this subject?
Before the presentation
[ Required ]
Select...
None
Little
Some
Considerable
Expert
After the presentation
[ Required ]
Select...
None
Little
Some
Considerable
Expert
Based on the 2026 ACC/AHA Multisociety Dyslipidemia Guideline, what LDL-C target is recommended for secondary prevention in patients with clinical ASCVD who are at very high risk?
[ Required ]
<40 mg/dL
<55 mg/dL
<70 mg/dL
<100 mg/dL
Which one of the following FDA-approved drugs/classes has shown the largest effect on Lp(a) lowering based on clinical trial data?
[ Required ]
Ezetimibe
PCSK9 inhibitors
Bempedoic acid
Inclisiran
How confident do you feel in your answer to the previous question?
[ Required ]
Select...
Very confident
Confident
Somewhat confident
Not confident
What would you like to learn more about on this subject?
Submit